CSF and blood Kallikrein-8: a promising early biomarker for Alzheimer's disease.

Sarah Teuber-HanselmannJan RekowskiJonathan VogelgsangChristine von ArnimKathrin ReetzAndreas StangKarl-Heinz JöckelJens WiltfangHerrmann EsselmannMarkus OttoHayrettin TumaniArne HerringKathy Keyvani

Published in: Journal of neurology, neurosurgery, and psychiatry (2019)

This is the first study to demonstrate the potential clinical utility of blood and CSF KLK8 as a biomarker for incipient AD. Future prospective validation studies are warranted.

Keyphrases

climate change